Genpact (G) to Release Earnings on Thursday

Genpact (NYSE:G) is projected to release its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.93 per share and revenue of $1.3079 billion for the quarter. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS and its Q4 2025 guidance at 0.930-0.940 EPS. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 5, 2026 at 5:00 PM ET.

Genpact (NYSE:G) last issued its quarterly earnings data on Thursday, November 6th. The business services provider reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.07. Genpact had a return on equity of 22.55% and a net margin of 11.01%.The business had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same quarter in the previous year, the firm posted $0.85 EPS. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. On average, analysts expect Genpact to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Genpact Stock Down 1.0%

Shares of G opened at $44.80 on Thursday. The company has a market capitalization of $7.72 billion, a price-to-earnings ratio of 14.45, a PEG ratio of 1.34 and a beta of 0.75. Genpact has a 52 week low of $37.49 and a 52 week high of $56.76. The stock’s 50-day moving average price is $46.34 and its 200-day moving average price is $43.93. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.33.

Analyst Ratings Changes

Several equities research analysts have commented on G shares. Weiss Ratings restated a “hold (c+)” rating on shares of Genpact in a research report on Friday, December 26th. Wall Street Zen upgraded shares of Genpact from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. Citigroup raised shares of Genpact to a “hold” rating in a report on Thursday, October 23rd. Finally, Susquehanna initiated coverage on shares of Genpact in a research report on Friday, December 12th. They set a “neutral” rating and a $50.00 price target on the stock. Two equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $50.50.

Insider Transactions at Genpact

In other news, Director Tamara Franklin sold 2,750 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total value of $125,537.50. Following the completion of the sale, the director directly owned 22,236 shares of the company’s stock, valued at approximately $1,015,073.40. The trade was a 11.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Sameer Dewan sold 15,088 shares of Genpact stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total value of $703,855.20. Following the transaction, the senior vice president directly owned 37,749 shares in the company, valued at approximately $1,760,990.85. This trade represents a 28.56% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 60,385 shares of company stock worth $2,762,475. Corporate insiders own 2.80% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Morningstar Investment Management LLC purchased a new stake in shares of Genpact during the 3rd quarter worth approximately $209,000. Scotia Capital Inc. acquired a new position in Genpact during the third quarter worth $227,000. Legacy Advisors LLC purchased a new stake in Genpact during the third quarter worth $272,000. Orion Porfolio Solutions LLC grew its holdings in Genpact by 6.7% in the third quarter. Orion Porfolio Solutions LLC now owns 5,891 shares of the business services provider’s stock valued at $247,000 after purchasing an additional 368 shares during the last quarter. Finally, WealthCollab LLC increased its position in shares of Genpact by 19.6% in the second quarter. WealthCollab LLC now owns 3,167 shares of the business services provider’s stock valued at $139,000 after buying an additional 519 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Genpact Company Profile

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.